Long QT Syndrome medical and device therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Long QT Syndrome}}
{{Xyz}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  


==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the secondary prevention of [disease name].


OR
OR


There are no available vaccines against [disease name].
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].


OR
==Secondary Prevention==
 
There are no established measures for the secondary prevention of [disease name].
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
 
==Primary Prevention==
There are no established measures for the primary prevention of [disease name].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include:
*[Measure1]
*[Measure2]
*[Measure3]


OR
OR


[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
Effective measures for the secondary prevention of [disease name] include:
*[Strategy 1]
*[Strategy 1]
*[Strategy 2]
*[Strategy 2]
Line 44: Line 25:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]

Revision as of 18:19, 10 March 2020

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Long QT Syndrome medical and device therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Long QT Syndrome medical and device therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Long QT Syndrome medical and device therapy

CDC on Long QT Syndrome medical and device therapy

Long QT Syndrome medical and device therapy in the news

Blogs on Long QT Syndrome medical and device therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Long QT Syndrome medical and device therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References

Template:WH Template:WS